Armon Sharei’s SQZ Biotech announced it raised a $65 Million-Series D round, led by Temasek with participation from another new, US-based fund as well as additional participation from existing investors, including GV, Illumina Ventures, Invus, JDRF T1D Fund, NanoDimension, and Polaris Partners.
Meet The MIT PhD Who Just Raised $65 Million For His Clinical Stage Cell Therapy Company
